Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

Similar articles for PubMed (Select 12362568)

1.

Drug resistant tuberculosis.

Kamholz SL.

J Assoc Acad Minor Phys. 2002 Apr;13(2):53-6.

PMID:
12362568
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

4.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
5.

Drug-resistant and multidrug-resistant tubercle bacilli.

Petrini B, Hoffner S.

Int J Antimicrob Agents. 1999 Oct;13(2):93-7. Review.

PMID:
10595567
6.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
7.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

8.

[Multidrug-resistant tuberculosis].

Alcaide F, Santín M.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 13:54-60. Review. Spanish.

PMID:
19100168
9.

Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.

Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.

10.

Drug resistant Mycobacterium tuberculosis in Mexico.

Zazueta-Beltran J, León-Sicairos C, Canizalez-Roman A.

J Infect Dev Ctries. 2009 Apr 30;3(3):162-8. Review.

11.

Extensively drug-resistant (XDR) tuberculosis: an old and new threat.

Fattorini L, Migliori GB, Cassone A.

Ann Ist Super Sanita. 2007;43(4):317-9. Review.

12.

Strategies against multidrug-resistant tuberculosis.

Loddenkemper R, Sagebiel D, Brendel A.

Eur Respir J Suppl. 2002 Jul;36:66s-77s. Review.

13.

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.

Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.

14.

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, Hoffner SE.

Chest. 2009 Aug;136(2):420-5. doi: 10.1378/chest.08-2427. Epub 2009 Apr 6.

PMID:
19349380
15.

Multidrug-resistant tuberculosis.

Zager EM, McNerney R.

BMC Infect Dis. 2008 Jan 25;8:10. doi: 10.1186/1471-2334-8-10.

16.

Status of drug resistance in tuberculosis after the introduction of rifampicin in India.

Paramasivan CN.

J Indian Med Assoc. 2003 Mar;101(3):154-6.

PMID:
14603961
17.

[Epidemiology of drug-resistant tuberculosis: world--Europe--Poland].

Jagielski T, Augustynowicz-Kopeć E, Zwolska Z.

Wiad Lek. 2010;63(4):345-57. Review. Polish.

PMID:
21612049
18.
19.

Extensively drug-resistant tuberculosis: new strains, new challenges.

Banerjee R, Schecter GF, Flood J, Porco TC.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713. Review.

PMID:
18847407
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk